Drug intelligence / Profile preview

lidocaine hydrochloride + triamcinolone acetonide + povidone-iodine

Development stage
Approved
Lead developer
Preferred Pharmaceuticals
Modality
Small Molecules
Administration
Intraarticular, Intramuscular, Topical
01

Overview

This product is a **combination medical kit** containing three small-molecule components used together for office-based musculoskeletal or soft-tissue injection procedures: **lidocaine hydrochloride**, a local amide anesthetic that blocks voltage-gated sodium channels to provide rapid local anesthesia; **triamcinolone acetonide**, a synthetic glucocorticoid corticosteroid that activates the glucocorticoid receptor to suppress inflammatory signaling; and **povidone-iodine**, a topical iodophor antiseptic used to prepare the skin before injection. The kit has been marketed under multiple distributor-specific brand names for **joint, tunnel, and trigger-point injections**, typically supporting intra-articular or intramuscular administration workflows rather than representing a single co-formulated vial. Based on the provided context, it has been distributed by companies including Preferred Pharmaceuticals, SA3, and Asclemed USA, and FDA labeling indicates the kit labeling itself has not been approved by FDA and the product has not been found by FDA to be safe and effective.

Brand names
Physician EZ Use Joint Tunnel and Trigger KitLT KitLidolog KitJTT Physicians Joint, Tunnel and Trigger Kit
Other names
lidocaine hydrochloride + triamcinolone acetonide + povidone-iodinejoint tunnel and trigger kit
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on lidocaine hydrochloride + triamcinolone acetonide + povidone-iodine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine hydrochloride + triamcinolone acetonide + povidone-iodine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call